Screener
Iovance Biotherapeutics, Inc. IOVA Business Segments — Royalty Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RoyaltyExpense.
The source filing: Iovance Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 9:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091716
| (in thousands) | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Cost of sales | ||||
| Cost of goods sold (excluding depreciation and amortization) (a) | $39,809 | $45,503 | $78,637 | $84,471 |
| Stock-based compensation | 1,536 | 2,149 | 2,555 | 4,569 |
| Royalties | 2,250 | 1,229 | 4,901 | 2,555 |
| Total cost of sales | $43,595 | $48,881 | $86,093 | $91,595 |
| Expenses | ||||
| Research and development | $53,773 | $71,569 | $111,143 | $137,619 |
| General and administrative | 18,617 | 19,668 | 37,317 | 39,524 |
Item 1.Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Iovance Biotherapeutics, Inc.'s business segments — royalty expense?
- Iovance Biotherapeutics, Inc. (IOVA) reported business segments — royalty expense of $2.25M in Q2 2026.
- How has Iovance Biotherapeutics, Inc.'s business segments — royalty expense changed year-over-year?
- Iovance Biotherapeutics, Inc.'s business segments — royalty expense increased by 83.1% year-over-year, from $1.23M to $2.25M.
- What does business segments — royalty expense mean?
- This represents the contractual payments made to third parties for the use of intellectual property or licensed technologies essential to the company's product offerings. It is a critical component of the cost structure that impacts the overall gross margin of the segment.
Ask your AI about Iovance Biotherapeutics, Inc.'s business segments — royalty expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude